Dhanuka P. Wasalathanthri

Bristol-Myers Squibb (Germany)

Papers

1

Total Citations

16

H-Index

1

About

Dr. Dhanuka P. Wasalathanthri is a leading figure in biopharmaceutical process analytics, pioneering the integration of advanced analytical technologies into biologics development and manufacturing. His work centers on "Process Analytics 4.0," a paradigm he helped define to address the growing complexity of novel therapeutic modalities. His most-cited paper, "Process Analytics 4.0: A paradigm shift in rapid analytics for biologics development" (2021, 16 citations), articulates a transformative framework for real-time, data-rich monitoring of product quality attributes and critical process parameters. This contribution is foundational for enabling continuous manufacturing and quality-by-design approaches in the biotech industry. Dr. Wasalathanthri’s research has significantly advanced the analytical toolset for biologics, bridging the gap between rapid, in-process testing and regulatory compliance. His work is widely recognized for its practical impact on accelerating development timelines and ensuring product consistency, making him a key voice in the evolution of smart biomanufacturing.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Process analytics 4.0: A paradigm shift in rapid analytics for biologics development
16 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Bristol-Myers Squibb (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago